Please login to the form below

F-Star

This page shows the latest F-Star news and features for those working in and with pharma, biotech and healthcare.

Cancer disruptor F Star names next CEO

Dr Eliot Forster takes reins from Dr John Haurum. UK-based biotech F-star has named Dr Eliot Forster as its new chief executive. ... I believe that F-star’s first-in-class molecules bring together in a single form, the full power of IO and combinations.

Latest news

BMS taps F-star Alpha for immuno-oncology drug

Drug in development for breast and stomach cancers. Bristol-Myers Squibb (BMS) has hatched a plan to buy Austrian biotech F-star Alpha in order to claim rights to FS102, a ... F-star has its headquarters in Vienna but runs its research operations out of
f-star wins €15m investment

Antibody specialist f-star secures funding from existing investors and adds new members to its supervisory board. ... f-star, a company developing antibody-based products, has secured 15m of new financing.
Survival strategy

During November and December 2010 there were five Big Pharma discovery deals involving Boehringer Ingelheim (with f-star), S-A (with Avila Therapeutics), Pfizer (with Phylogica), Tanabe Research Laboratories (with Anaphore) ... f-star/Boehringer
PM Society Awards 2005

These days you're lucky if you can give them a three-star hotel and a f ing biro. ... He also issued a thinly-veiled warning to any entrants who had been honoured with a highly commended': Congratulations and all that but stay in your f ing seat.

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Deal Watch table for October 2014

525. F-star Alpha/BMS. Option to acquire F-star Alpha. Includes FS102 a P1 ready treatment for HER2 positive patients with breast / gastric cancer.
Pharma deals during October 2014

A major feature throughout 2014 has been the deployment of options. This month is no exception with Bristol-Myers Squibb (BMS) securing an exclusive option to acquire F-star Alpha gaining

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

New hires at FibroGen, Saniona and Turbine

Previously, she held the position of senior vice president of drug discovery at F-star, overseeing all internal and collaborative bispecific antibody discovery programmes.
F-star hires ex-BMS immuno-oncology leader

I believe F-star is ideally positioned to become the next leader in this field.”. ... Eliot Forster, CEO of F-star, said: “We are delighted to welcome Louis to the F-star team.
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

Jallal will succeed Andrew Hotchkiss, who has served as interim CEO after Eliot Forster (pictured above) left the company to head up cancer disrupter F Star last year.
ImmuneXcite boosts senior leadership

Edwards is currently executive chairman at F-star, having previously served as its chief executive officer, and brings over 30 years of biotechnology expertise from Adnexus Therapeutics, Genetics Institute/Wyeth and
F-star appoints vice president of protein sciences

Mike Davies joins from CPI Biologics. Vienna-headquartered biopharmaceutical company F-star has appointed Mike Davies as vice president of protein sciences at its Cambridge, UK research site. ... John Haurum, chief executive officer of F-star, said:

More from appointments
Approximately 3 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Account Management: Competitive Salary Offered

Senior Content Editor - Biotechnology: Salary TBC

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

Freelance Account Manager - Creative Healthcare Comms - Immediat...: Excellent Day Rate

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Principal Medical Writer: Varies on experience

PMHub

Add my company

Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Virtual congresses: video thrilled the cardio tsar: Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?: The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.: Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....